Science & Enterprise subscription

Follow us on Twitter

  • Discoveries in a university lab that enable detection of Covid-19 infections from a person's breath are being licen… https://t.co/DgmvR2EcTr
    about 8 hours ago
  • New post on Science and Enterprise: Breath Analysis Sensor Licensed to Detect Covid-19 https://t.co/IZh1x1rqfo #Science #Business
    about 8 hours ago
  • Seven new vaccine projects got underway last week, raising the total to 164, with six more vaccines reaching clinic… https://t.co/VvvPn7PGgu
    about 16 hours ago
  • New post on Science and Enterprise: Covid-19 Vaccines, Therapies – 10 August 2020 https://t.co/RY6ggjx9Eu #Science #Business
    about 16 hours ago
  • Physical symptoms experienced by people with Covid-19 infections are well documented, but the psychological toll is… https://t.co/e2pEpA3nlP
    about 3 days ago

Please share Science & Enterprise

Breath Analysis Sensor Licensed to Detect Covid-19

Birthday candles

Discoveries in a university lab that enable detection of Covid-19 infections from a person’s breath are being licensed for development by a biotechnology company. . . . → Read More: Breath Analysis Sensor Licensed to Detect Covid-19

Start-Up to Engineer T-Cells for Autoimmune Diseases

Human T-cell

GentiBio Inc., a new enterprise in Boston, is starting work on creating engineered T-cells from the immune system to treat autoimmune diseases. . . . → Read More: Start-Up to Engineer T-Cells for Autoimmune Diseases

New Allergy Biotech Launches, Raises $10M

Peanutes in shells

A new company developing treatments to relieve allergic reactions with reprogrammed antibodies began work and is raising $10 million in its first venture funding round. . . . → Read More: New Allergy Biotech Launches, Raises $10M

Neuro Disease Start-Up Raises $73M in Early Funds

Neuron

A company developing new therapies for neurodegenerative diseases officially began operations, staked to $73 million raised in its first venture round. . . . → Read More: Neuro Disease Start-Up Raises $73M in Early Funds

Synthetic Protein Designed to Boost Covid-19 Vaccines

Jason McLellan and Daniel Wrapp

Researchers in Texas designed a synthetic version of a protein found on Covid-19 viruses that can make it easier to produce more vaccines. . . . → Read More: Synthetic Protein Designed to Boost Covid-19 Vaccines

Start-Up Developing Inside-Cell Delivery, Gains $28.5M

Vesicles

A new company spun-off from Harvard University is developing techniques for delivering advanced genetic and protein therapies directly inside cells. . . . → Read More: Start-Up Developing Inside-Cell Delivery, Gains $28.5M

Tough Surgical Adhesive Commercially Licensed

Gel adhesive

A bio-materials company is acquiring the rights to develop dental sutures and membranes from an adhesive gel developed in a university lab. . . . → Read More: Tough Surgical Adhesive Commercially Licensed

New Company Offers A.I. Aging Biomarker Analysis

Older couple

A new enterprise is underway using artificial intelligence to analyze a person’s body chemistry and calculate the likelihood of age-related diseases. . . . → Read More: New Company Offers A.I. Aging Biomarker Analysis

Univ. Lab Discovers, Licenses Citrus Disease Treatment

Australian finger lime

Plant scientists in California discovered a natural peptide that stops bacteria from causing citrus greening, a disease destroying citrus crops worldwide. . . . → Read More: Univ. Lab Discovers, Licenses Citrus Disease Treatment

Crispr Heart Therapy Demonstrated in Monkeys

Heart and major blood vessels

An experimental therapy using a precise gene editing technique is shown in lab monkeys to reverse the cause of a chronic form of heart disease. . . . → Read More: Crispr Heart Therapy Demonstrated in Monkeys